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Implants and their interaction with organism
General term of implantation implies insertion of bio-
materials of different designs into the tissues. Oral implanta-
tion is a surgical insertion of aloplastic materials (metals, al-
loys, ceramics, polymers, carbons as well as their combina-
tions) into the hard and soft tissues of the upper and lower
jaws 1.
The essence of implantology lies in favorable reaction
of the organism to the presence of foreign body or favorable
response of the bone tissue to implant material. The organ-
ism reaction is the development of inflammation resulting in
a complete recovery of tissues and acceptance of implants or
its loss. Implantation is a traumatic damage of the soft and
hard tissues. Regardless of how much the procedure has been
carefully conducted, tissue response is controlled by mecha-
nisms of bone healing metabolism, as well as by other
biomechanisms. As with every other tissue damage, the or-
ganism reacts with inflammation with the aim to limit the
damage or to replace the lost or damaged tissue with the pro-
cesses of regeneration or reparation 2. Metabolic activities of
the bone marrow and the constant process for bone remod-
eling are important prerequisites of the long-term implant
stability. Successuful outcome of implant placement depends
on: implant material, design, adequate patient selection and
proper indicators, careful surgical technique used and crea-
tion of functional and esthetic prosthetic restoration.
Each implant material should be: biocompatible, bioin-
ert, biofunctional and bioadhesive 1.
Biocompatibility means that implant material is not
toxic, cancerogenic, allergenic, i.e. induces no immune reac-
tion. In other words, histocompatibility is a “harmony” of
implant material and living tissues that do not harm each
other. Bioinertia primarily refers to material insolubility and
stability, and resistence to corrosion, in tissue fluids. Bio-
functionality includes implant design, its strenght and ability
to withstand loading conditions. Bioadhesion is characterized
by close intimate contact of implant surface and the sur-
rounding tissuess. Ideal implant material which meet all the
four-mentioned criteria has not yet been produced, but the
common opinion is that it is sufficient that the human organ-
ism tolerates inserted material.
The condition of peri-implant soft and hard tisuess is
highly significant for implant longevity and function 3. The
main role of soft tissue surrounding implants is to provide
the hermetic seal and protective barrier between oral cavity
and the internal peri-implant bone, thus preventing invasion
of various pathogens. Bone tissue, on the other hand is re-
sponsible for implant osseointegration, stability, overtime
and distribution of masticatory forces. There are many con-
tradictory facts concerning peri-implant tissue. It is believed
that hemidesmosome and basal membrane, similar to natural
tooth, are the mediators for epithelial cell adhesion to the
implant surface 4.
Peri-implantitis
Peri-implantitis is defined as an inflammatory reaction
with the loss of supporting bone in the tissues surrounding a
functioning implant. Peri-implant diseases are classified ac-
cording to the part of the oral tissue involved in the inflam-
matory process. If inflammation is located only the gingival
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tissue around the implant neck is defined as peri-implant
mucositis. Progression of inflammation results in bone loss
adjacent to the implant causing peri-implantitis. The onset of
peri-implantitis is in the marginal bone adjacent to the coro-
nary part of the implant while its apical part remains osseo-
integrated. The implant is clinically stable, while the last sta-
dium where a complete loss of bone-to-implant contact oc-
curs. If left untreated, it can result in implant loss. Numerous
clinical studies have reported near 4% implant loss 4–6.
Risk factors that can lead to peri-implantitis are local
(microbial plaque, parafunctions, smoking, poor oral hy-
giene) and general, i.e. susceptibility to peri-implantitis, is
determined by genetic factors or the influence of some sys-
temic diseases.
Two main etiological factors that significantly contrib-
ute to the onset of peri-implant mucositis and resorption of
the marginal part of the bone tissue are bacterial infection
and biomechanical factors resulting from the excessive
loading the implants in function 7.
Excessive overload of implants can cause microfrac-
tures in marginal bone region and cause the loss of oseointe-
gration around the neck of the implant.
Plaque accumulation and microbial contamination of
peri-implant tissue cause inflammation of subepithelial con-
nective tissue with massive inflammatory cell infiltrations.
Epithelial seal is loosely fixed, suppuration can occur, clini-
cal as well radiographical signs of tissue destruction can be
observed.
A microbiological research has shown that subgingival
bacterial flora, isolated in peri-implantitis, is completely dif-
ferent from the microbiological findings around implants
with no signs of inflammation. Considering oral microflora
as a possible risk factor for peri-implant tissue disease, the
evidence suggest that no significant differences exist in the
distribution of bacterial morphotypes around implants and
teeth respectively.
Dominant microorganisms isolated from the subgingi-
val plaque in the case of periimplantitis are Gram-negative
bacilli and spirochetes. The number of spirochetes is in posi-
tive correlation with the quantity of plaque, pockets depth
around the implants and bone resorption. Apart from spiro-
chetes, other isolated bacilli are: Prevotella intermedia, Ag-
gregatibacter actinomycetemcomitans, Porphyromonas gin-
givalis, Fusobacterium nucleatum, Actinomyces i Haemo-
philus 8.
Mombeli and Lang 9 in 1994 were the first to report on
the interaction of microbiological flora and implant failure.
In cases of successful implants, i.e. osseointegrated cocci
predominated, whereas in the cases of peri-implantitis a sig-
nificant increase of spirochetes was observed. Progression to
peri-implantitis from perimucositis does not always occur,
just as every case if gingivitis does not progress to periodon-
titis. Microbial differences between partially and completely
edentulous patients were explored 10.
Increase susceptibility to peri-implantitis was described
in partially edentulous jaws 10.
The assessment of the degree of inflammation is based
on clinical and radiographic findings. Clinical signs include
the status of peri-implant soft tissue, implant stability and
general signs of inflammation which are evident in the ad-
vanced stages of peri-implantitis: peri-implant soft tissue oe-
dema, redness, bleeding on probing, increased probing depth,
suppuration, pain.
Radiographic findings reveal increased bone resorption
which is presented on the mesial and distal aspects of the
implant neck as a V – shaped radiolucency. Although stan-
dard radiographic examination is the most common method
used, it is not completely precise, because the buccal and oral
aspects of the peri-implant bone tissue cannot be evaluated.
Cytokines in inflammation
Cytokines comprise a group of soluble, low molecular
proteins, unspecific mediators of an inflammatory reaction
that transfer various intercell signals necessary for the inte-
grated cell response to different exogenous stimuli both in
physiological and pathological conditions. Cytokines are se-
creted by lymfocytes, by the cells of the monocyte macro-
phage systems, by thrombocytes and many other non-
circulating cells. They modulate inflammation and immune
reactions by regulating the growth, mobility and differentia-
tion of leukocytes and other cells, and all together are im-
portant in pathophysiology of numerous diseases 11.
Cytokines can be classified according to their similarity
in dominant biological activities related to the target cells,
similarities in their origin, structural similarity and similitary
of the receptors through which they act.
Most of cytokines show biological effects through spe-
cific receptors on the membranes of target cells. Linking of
cytokines to receptors triggers the intercell signals that result
in specific changes in genetic expression of the target cells.
Some of cytokines express chemotactic effect, whereas
the other express direct cytotoxic or antiviral effect.
Cytokines play an important role in pathogenesis of al-
most all of systemic and local diseases. They represent im-
portant mediators of physiological and pathological activities
in the tissues of orofacial region 12. One of the most spread
out diseases of orofacial region is periodontal disease which
when left untreated results in the loss of teeth, when dental
implants can be used as a one of treatment modalities. De-
tection of cytokines in clinical laboratories is important be-
cause it can provide following of progression and activity of
numerous disesase. In research laboratories, evaluation of
cytokine gene expression has been investigeted expecting
that this kind of research would provide better explanation of
mechanisms of cytokine effect in the process of periodontal
diseases.
The role of cytokines in peri-implantitis
Local response to peri-implant bacterial infection is in
immunological and biochemical aspect very similar to the re-
sponse in periodontal disease, which has been reported in
many studies 13, 14.
Page et al. 15 set a hypothesis in 1997 that the progres-
sion of periodontal disease depends on: the presence and ac-
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tivity of pathogenic bacteria; high local production of proin-
flammatory mediators (cytokines), extracellular matrix met-
alloproteinasis (MMP) and prostaglandin (PGE); low local
production of inihibitors of inflammatory processes, par-
ticularly cytokines with immunosuppressive action, such as
interleukin (IL) 10 (IL-10), factor of growth transformation
beta 1 (TGF-β1) and MMP inhibitors.
Local balance of these mediators that reflects local ac-
tivity of cells that produce them, determines the level of tis-
sues destruction. Pathohistological substrate of disease con-
sists of mononuclear cell infiltrate, the composition of which
significantly transforms depending on the advancement of
the process. Namely, predomination of T lympocytes in early
lesions, is slowly replaced by B lymphocytes infiltrate in
late, chronic or acute lesions.
Based on the determination of the produced cytokines
profiles and types of cell infiltrates, there are at least three
well – argumented and oppose theories of pathogenesis of
the onset of periodontitis from the initial gingivitis.
Seymour et al. 16 in 1993 claim that the change of pre-
dominant T lymphocyte infiltrates in gingivitis into the
dominant B lymphocyte infiltrate in periodontitis is mediated
by the excessive local production of Th2 type cytokines. Th2
cytokines (IL-4, IL-5, IL-10, IL-13) cause local proliferation
and differentation of B lymphocytes, local secretion of non-
protective antibodies specific for antigene bacteria determi-
nants and hyperproduction of IL-1, which leads to the lesion
progression.
This is not in agreement with Ebersole and Taubman 17
who claim that the local production of Th2 type cytokines is
important for local immune response, because it stimulates
the production of specific antibodies, as well as the produc-
tion of anti-inflammatory cytokines: IL-4, IL-10, IL1 recep-
tor antagonist (IL1-RA), which can stop the onset or delay
the progression of periodontal lesion. According to the same
authors, the onset, longevity and progression of the lesion is
the consequence of specific CD8+ T lymphocytes activities.
Tissue damage caused by cytotoxic CD8+ T lymphocytes,
can be direct or is the result of production of proinflamma-
tory cytokines (IFN-γ, IL-1) that stimulate destructive proc-
esses of local macrophages and osteoclasts.
Contrary to these hypotheses, Dennison and Van Dyke 18
claim that macrophages and their altered functions are
mainly responsible for the pathogenesis of a periodontal le-
sion. Namely, according to them macrophages represent the
effectory cells that manage the activities of osteoclasts and
osteoblasts. An adequate production of one of the key Th2
cytokines, IL-4, inhibits the activation of macrophages, the
presence of antigenes, production of proinflammatory cyto-
kines necessary for triggering an adaptive immune response
and increases the apoptosis of macrophage, resulting in the
delay in onset of periodontal lesion. Interferon (IFN)-γ key
Th1 cytokine has the opposite effect.
Peri-implantitis is a result of an unregulated inflamma-
tory response of the host to antigene bacterial determinants
from dental plaque. The basis of peri-implantitis consists of
an interactions complex that is established between bacterial
products, host cells and locally produced biological active
factors. The degree and outcome of the destructive processes
is determined by the nature of inflammatory response at the
local level.
The capability of immune effectory cells to produce
and release cytokines in response to stimulation of bio-
logical agents is a good strategy for monitoring the condi-
tion of peri-implant tissues. Because of this, the research
of cytokines local production on the region of inflamma-
tion gives relevant data on the state of peri-implant tissues
in relation to the monitoring of production of cytokines in
peripheral blood. The balance between stimulatory and in-
hibitory cytokines, together with the regulation of expres-
sion of their receptors and signal cascades determine the
level of peri-imiplant tissues destruction. Namely, the lo-
cal balance of these mediators, which reflects the local ac-
tivity of cells that produce them, determine the level of tis-
sue destruction.
Cytokines that are present in peri-implant tissues can be
diagnosed by measuring their concentrations in peri-implant
fluid (PICF). This fluid fills the peri-implant sulkus and cy-
tokines present in it, reflecting physiological interaction of
gingival epithelium and local leukocytes on the microo-
granisms of dental plaque and oral flora 19. Microorganisms
are capable of synthesizing detrimental products that damage
epithelium and connecting tissue cells and extracellular con-
tent.
Periotron is a device that precisely collects and deter-
mines the volume of peri-impant fluid. Cytokines are mostly
detected by commercial cytokine kits (ELISA test). How-
ever, some other immunological essays for simultaneous de-
tection of multiple cytokines from small samples have re-
cently been developed.
Over the last ten years, the role of cytokines as useful
diagnostical indicators that might represent an important ad-
dition to clinical parameters has been considered, and which
might indicate the presence or absence of peri-implant dis-
ease, or indicate the treatment result that, in same cases may
include the need for additional medical procedures.
Increased level of proinflammatory cytokines and che-
mokines significantly correlates with the level of inflamma-
tion 20, 21.
Local production of cytokines can depend on the in-
teraction of specific microorganisms with gingival tissue,
but also on the function of residential and infiltrating cells.
In these complex events, one of the earliest one is the in-
crease in production of IL-1β by gingival macrophages,
which then induces, among other things, the secretion of
IL-8. These two cytokines direct the selective migration of
polymorphonuclear and monocytes from the gingival blood
vessels, which are locally activated by the action of bacte-
rial lipopolysacharide. Activated cells further produce dif-
ferent mediators, out of which the most impotrant are IL-
1β, IL-6 and IL-8. The progression of gingival inflamma-
tion is probably the consequence of IL-1β and IL-6 activi-
ties, which cause an important tissue damage by the activa-
tion of osteoclasts and induction of collagen synthesis and
fibroblasts 22. In Figure 1 cells involved in the inflamma-
tory response are presented.
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Proinflammatory cytokines and chemokines are very
expressed in the peri-implant tissue in the early stages of in-
flammation when an implant is inserted. Panagakos et al. 22
and Salcetti et al. 23, by determining the values of IL-1β in
the fluid of peri-impant sulkus, showed that concentration of
this cytokine is increased by the progression of peri-
implantitis. Most of the authors showed that tissue inflam-
mation is proportionally connected with the increased level
of different inflammatory mediators, which are, therefore,
considered as adequate markers of inflammation. The results
of Curtis et al. 24 show that there is a significantly lower level
of concentration of proinflammatory cytokines in healthy tis-
sue around implant compared to the advanced stage of peri-
implantitis.
Chemokines and cytokines provide a complex network
of signals that can activate or suprime an inflammatory re-
sponse.
The clinical study performed in the Military Medical
Academy monitored the levels of the following 4 cytokines:
IL-1β, IL-8, tumor necrosis factor (TNF)-α and macrophage
inflammatory protein-1 alpha (MIP-1α) 21. Proinflammatory
cytokines IL-1β and TNF-α are significant in immune re-
sponse to microbial antigenes, whereas different levels of
concentration of chemokines IL-8 and MIP-1α, can affect the
migration of leukocites and together with TNF-α and IL1-β
regulate the onset, course and outcome of inflmammation.
The research showed that the concentrations of proin-
flammatory cytokines and chemokines were singificantly
higher in the patients with peri-implantitis in relation to the
ones with perimucositis and the healthy ones. With the pro-
gression of peri-implantitis, the concentrations of all the re-
searched cytokines in PICF were increased, but there were
also individual differences in the level of the increase pro-
duction of mediators of the inflammation. There has been a
positive and statistically significant correlation between the
levels of IL-1β and MIP-1α, TNF-α and MIP-1α as well as
MIP-1α and IL-8 in PICF.
Proinflammatory cytokines (IL-1β, TNF-α) are im-
portant mediators of inflammatory host responses to the in-
fection and other inflammatory stimuli and therefore have
an important role in natural immunity and inflammation.
IL-1β is a proinflammatory cytokine in certain concentra-
tion present in healthy peri-implant tissue and its value
shows the real level of inflammation of peri-implant tis-
sues. This local parameter of immune reactivity can be used
for evaluation of the states of peri-implant tissues. It regu-
lates degradation of the connective tissue and modulates
the reparative activity by the induction of the endothel cells
by proliferation of fibroblasts and hemotaxis of neutrophils
in inflammated gingiva. Concentrations of IL-1β in PICF
are increased in the early stages of peri-implantitis with the
tendency of further increase with the progression of the
disease 22, 25, 26.
IL-1β and TNF-α act synergically including stimulation
of bone resorption 27.
The levels of IL-1β in PICF were approximately three
times higher in patients with the evident peri-implantitis
compared to healthy controls 25. Also, the values of IL-1β
showed a positive correlation with clinical parameters of the
disease.
A significantly increased level of IL-1β in PICF have
been detected in regions with failed dental implants com-
pared to the level of this cytokine in PICF with successful
control implants 23, 24, 28.
Murata et al. 29 have analysed the levels of osteocalcin,
deoxipiridinolin and IL-1 β as the markers of bone metabo-
lism in PICF in patients with peri-implantitis. The volume of
PICF as well as the levels of IL-1ß in regions with peri-
implantitis were significantly higher than in regions with
mucositis or with helthy gingiva. The conclusion of this
study is that IL-1β was an effective marker for evaluation of
periimplant inflammation.
Curtis et al. 24 after their extensive research, come to a
conclusion that the measurement of IL-1β in PICF as local
parameter of immune reactivity, can be an important addition
to clinical results in the diagnosis of peri-implantitis. Aver-
age values of cytokines of PICF were three times higher in
relation to the values in the initial stage.
Many studies 22–24 have shown that IL-1β is present in:
small, but detectable concentrations in gingival fluids around
Fig. 1 – Cells involved in the inflammatory response
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clinically heatlhy implants; moderately high concentrations
in samples of PICF of patients with early stages of peri-
imiplantitis and high concentrations in the samples of PICF
of patients with advanced peri-implantitis.
Based on the numerous studies it is possible to summa-
rize the role of proinflammatory cytokines (IL-1β, TNF-α) in
peri-implantitis: they enable migration of inflammatory cells
into the tissue (they are included in the acute-phase response
against the infection and pathogenesis of peri-implant de-
struction); they stimulate the processes of inflammation and
tissue destruction; they induce and increase bone resorption;
they stimulate the release of MMP that cause degradation of
proteins of extracellular matrix and, apart from the local, af-
fect the systemic manifestation of inflammation.
Unlike proinflammatory cytokines, hemokines belong
to the family of chemotactic cytokines that stimulate and
regulate migration of leukocytes from the blood into the tis-
sues.
Inflammatory cells can release different chemokines
and there is a proof that infection of specific bacteria and vi-
ruses can stimulate the cells of hosts to produce characteris-
tic sets of immune cells.
As it has previously been emphasized, Th1, Th2 and
Th17 play a significant role in the pathogenesis of peri-
implantitis, but that role is still not well-known.
Activation of Th1 subpopulation cells through IL12 re-
sult in the production of IL-2 and IFN-γ. These cytokines
stimulate predominatly the cell immune response mediated
by the cytotoxic T-cells, macrophages and natural killer
(NK) cells. On the other hand, activation of Th2 subpopula-
tion cells is followed by the production of IL-4, IL-5, IL-6
and IL-10, which stimulates a predominantly humoral im-
mune response and inhibits the cells immune response. Th17
is a new subtype of CD4+ T cells that is significant for the
immunity to bacteria, but also for the pathogenesis of auto-
immune processes. The level of IL-17, the most important
representative of this type of cytokine, is increased during
gingivitis and periodontal diseases 30. So far it has not been
investigated in peri-implantitis.
The relation of bacteria in dental plaque determines the
direction of pathological mechanisms. If plaque accumulates
on implant surface, the subepithelial connective tissue is in-
filtrated by the inflammatory cells. According to numerous
studies 21, 29, 30, together with the progression of peri-
implantitis, concentrations of all the examined cytokines in
PICF are increased, but also that there are individual differ-
ences in the rate of increase in the production of these in-
flammatory mediators. Therefore, there is a difference in
concentration of cytokines of PICF depending on the stage of
peri-implantitis, which indicates the interaction of cytokines
concentration and clinical parameters.
Many researchers tried to modify pathological re-
sponses by manipulating cytokine interaction within the tar-
geted peri-implant tissue 31, 32. The discovery of new cytoki-
nes and identification of new activities for the existing cyto-
kines have significantly contributed to understending immu-
nopathogenesis of peri-implant disease.
The detection of cytokines as valid biomarkers of
pathological process, can be very effective because it pro-
vides more precise explanation of patophysiological mecha-
nism of the disease itself. Also, evaluation of cytokine pro-
duction can be for the benefit of monitoring the immune
status of the organism.
Conclusion
The diagnosis and monitoring of many systemic dis-
eases in medicine in most cases is based on laboratory analy-
ses of biological fluids, secrets and tissues. Therefore, in the
last ten years, research in the field of implantology have also
been focused on the analysis of peri-implant fluids with the
basic aim to identify potentially valid biochemical and im-
munological markers of the level of activity of inflammatory
processes and/or to predict risk for the onset of peri-implant
disease.
The results of the clinical research so far have shown
that monitoring of the levels of proinflammatory cytokines
and chemokines in peri-implant fluid can be used for moni-
toring of disease progression, as well as for its early detec-
tion.
The role and interaction of Th1, Th2 and Th17 cytoki-
nes in these processes are still less understood.
Monitoring of dynamics of local cytokine levels during
peri-implantitis, together with research of gene polymor-
phism for these cytokines and other genes included in the in-
flammatory process, and the correlation with clinial parame-
teres can be valid means for the diagnosis, prognosis and ap-
plication of new peri-implant treatment methods.
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